Back

The impact of SGLT2 inhibitors on indices of cardiac function: An updated systematic review and meta-analysis

21 May 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Modern technologies in heart failure Antidiabetic Pharmacotherapy HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Panagiotis Theofilis

Hippokration General Hospital, Athens (Greece)

5 More presentations in this session

Presentation thumbnail
How to calculate the anaerobic threshold to stratify HF prognosis: a comparison between absolute value, percentage of peakVO2 or percentage of predicted maxVO2 ina large multicenter cohort of HFrEF
Doctor E. Salvioni (Milan, IT)
Abstract Slides Video
Presentation thumbnail
An inflamed relationship - increase in serial galectin-3 identifies males at risk of developing heart failure and cancer.
Mr F. Van Den Berg (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Protocol based versus mobile application based 6-minute walk test. A validation study
Doctor L. Klompstra (Linkoping, SE)
Abstract Slides Video
Presentation thumbnail
The impact of renal denervation on diastolic function in patients with resistant hypertension and heart failure with preserved ejection fraction: one year follow-up
Doctor A. Moiseeva (Chisinau, MD)
Abstract Slides Video
Presentation thumbnail
Machine learning models to predict elevated plasma NT-proBNP concentration in a clinical trial population
Mr C. Li (Glasgow, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Modern technologies in heart failure
Video

The Event

Event poster

Heart Failure 2022

21 May - 24 May 2022
You may be interested in
thumbnail
Congress Presentation
Case 1 - a middle-aged male with T2DM: polypharmacy in a primary prevention setting
thumbnail
Congress Presentation
Hypertension and glucose
thumbnail
Congress Session
Guidelines in Practice: 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources